Massachusetts regenerative medicine and clinical research company offering fat-derived cell and platelet treatments for orthopaedic, hair and anti-ageing use.
Regeneris Medical describes itself as a healthcare and clinical research organisation working in regenerative medicine, and states it has operated in the field since 2009. It treats patients and also runs clinical research. The practice is associated with North Attleboro, Massachusetts in its own listing, but the address published on the company overview page reviewed was 315 University Ave, Westwood, MA 02090, so confirm which site you should attend before travelling.
The main biological products described are platelet-rich plasma (PRP), concentrated from the patient's blood, and stromal vascular fraction (SVF), a mixed cell preparation obtained from the patient's own fat through liposuction. The site describes the SVF preparation as yielding roughly five hundred thousand to one million cells per cubic centimetre; this is the company's own published figure and has not been independently verified. The site describes both PRP and SVF as research-level therapies, which is a signal that these are not established, approved treatments.
The service areas listed are orthopaedics, anti-ageing, hair restoration and sexual wellness, alongside clinical research. The conditions named extend well beyond joints to include lupus, multiple sclerosis, muscular dystrophy, amyotrophic lateral sclerosis (ALS), Parkinson's disease and stroke recovery. Cell treatment for these serious neurological and autoimmune conditions is not an established therapy, and anyone approached about it should ask what regulatory approval or trial registration applies and seek an independent second opinion. No physician is named anywhere on the page reviewed, which is a significant omission.
This is a very broad list that ranges from joint pain to serious neurological disease. Cell therapy is not an established treatment for most of these conditions. Ask specifically what evidence and what regulatory approval or trial registration applies to your condition, and get an independent second opinion before proceeding.
The cells described are taken from the patient's own fat and blood. No donor or umbilical cord products are named.
No physician is named with credentials on the page reviewed. For an organisation offering cell treatment for serious neurological conditions, the absence of named, credentialed clinicians is a significant gap.
The company overview page gives an address of 315 University Ave, Westwood, MA 02090, while the page's own summary text refers to North Attleboro, Massachusetts. Opening hours, languages spoken and international patient services are not published. The company states it has worked in regenerative medicine since 2009.
No prices or consultation fees are published. Treatments of this kind are self-funded and can be substantial. Given that the site describes them as research-level therapies, ask whether any charge applies and what regulatory status the treatment has before committing money.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.